New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
06:31 EDTVSIVitamin Shoppe sees FY14 CapEx $35M-$40M.
Company sees FY14 retail store comparable sales growth of low to mid-single digits, and total comps including e-commerce, of mid-single digits; approximately 60 new stores; depreciation & amortization of approximately $31M; slight EBIT margin decline, reflecting lower Q1 expectations and capital expenditures of approximately $35M-$40M.
News For VSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
07:39 EDTVSIVitamin Shoppe Q2 results expected to be soft, says Baird
Baird expects Vitamin Shoppe to report soft Q2 results citing negative comps and significant EBIT margin compression. The firm noted investor sentiment is low heading into the results and that it expects more details on the new CEO's strategic position. Baird reiterated its Outperform rating and $45 price target on Vitamin Shoppe shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use